Studies on the signal transduction passways through IL-12 receptor
IL-12受体信号转导通路的研究
基本信息
- 批准号:14570285
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We performed a yeast two-hybrid screening and identified the mouse sphingosine kinase 2 (SPHK2) as a molecule associating with mouse IL-12Rβ1 cytoplasmic region. Analyses on various mutants of each molecule revealed that the region including proline-rich domain in SPHK2 is likely to be responsible for the binding to IL-12Rβ1, while the regions including the carboxyl terminus and Box II in IL-12Rβ1 cytoplasmic region appear to be involved in the binding to SPHK2. Transient expression of wild-type SPHK2 in T cell hybridoma augmented IL-12-induced STAT4-mediated transcriptional activation. Ectopic expression of dominant-negative SPHK2 in Th1 cell clone significantly reduced IL-12-induced IFN-γ production, while that of wild-type SPHK2 enhanced it. In contrast, the expression minimally affected IL-12-induced proliferation. Similar decrease in IL-12-induced IFN-γ production was observed when dominant-negative SPHK2 was expressed in activated primary T cells by using a retroviral expression system. These results suggest that SPHK2 associates with IL-12Rβ1 cytoplasmic region and is likely to play a role in modulating IL-12 signaling. We also investigated the JAK/STAT signaling molecules activated by IL-27 and the role of STAT1 in IL-27-mediated responses using STAT1-deficient mice. We found that IL-27 activated JAK1, -2 TYK2, STAT1,-2,-3, and -5 in naive CD4+ T cells. Comparable proliferative response to IL-27 was observed between STAT1-deficient and wild-type naive CD4+ T cells. In contrast, IL-27 failed to induce T-bet arid IL-12Rβ2 expression, and synergistic IFN-γ production by IL-27 and IL-12 was also impaired in STAT1-deficient naive CD4+ T cells. These results suggest that IL-27 activates JAK1,-2, TYK2, STAT1, -2,-3, and -5 in naive CD4+ T cells and that STAT1 plays an indispensable role in IL-27-induced T-bet and IL-12Rβ2 expression but not proliferation.
我们进行了酵母双杂交筛选,鉴定出小鼠鞘氨醇激酶2(SPHK2)是一个与小鼠IL-12Rβ1细胞质相关的分子。对每个分子的各种突变体的分析表明,SPHK2中的富含Pro结构域的区域可能与IL-12Rβ1结合,而IL-12Rβ1细胞质区域中的羧基末端和框II似乎参与了与SPHK2的结合。野生型SPHK2在T细胞杂交瘤中的瞬时表达增强了IL-12诱导的STAT4介导的转录激活。在Th1细胞克隆中异位表达显性负性SPHK2显著降低了IL-12诱导的干扰素-γ的产生,而野生型SPHK2的异位表达则增强了IL-12诱导的干扰素-DNA的产生。相反,该基因的表达对IL-12诱导的增殖影响最小。用逆转录病毒表达系统在激活的原代T细胞中表达显性阴性的SPHK2时,IL-12诱导的干扰素-γ的产生也有类似的下降。这些结果表明,SPHK2与IL-12Rβ1胞浆区相关,可能在调节IL-12信号转导中发挥作用。我们还研究了由IL-27激活的JAK/STAT信号分子,以及STAT1在IL-27介导的反应中的作用。我们发现IL-27在初始的CD4+T细胞中激活了JAK1、-2、TYK2、STAT1、-2、-3和-5。在STAT1缺陷和野生型初始CD4+T细胞之间也观察到了类似的对IL-27的增殖反应。IL-27不能诱导T-bet和IL-12Rβ-2的表达,IL-27和IL-12协同产生γ的作用也受到抑制。这些结果提示,IL-27能激活初始T细胞JAK1、-2、TYK2、STAT1、-2、-3和-5,STAT1在IL-27诱导的T-bet和IL-12Rβ-2的表达中起着不可缺少的作用,但不能促进增殖。
项目成果
期刊论文数量(54)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
M.Shimizu et al.: "Modification of tumor cells with Fas(CD95)antigen gene and Fas ligand(CD95L)gene transfection by electroporation for immunotherapy of cancer."Mol.Biotechnol.. 25. 79-87 (2003)
M.Shimizu 等人:“通过电穿孔用 Fas(CD95) 抗原基因和 Fas 配体 (CD95L) 基因转染对肿瘤细胞进行修饰,用于癌症的免疫治疗。”Mol.Biotechnol.. 25. 79-87 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Hisada: "Potent anti-tumor activity of interleukin-27."Cancer Res.. 64. 1152-1156
M.Hisada:“白细胞介素 27 具有有效的抗肿瘤活性。”癌症研究 64. 1152-1156
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H.Suzuki: "Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co-operatively induce apoptotic cell death in both sarcoma and myeloma cells."Anticancer Res.. 23. 3247-3254 (2003)
H.Suzuki:“逆转录病毒介导的 TRAIL 转导和化疗药物协同诱导肉瘤和骨髓瘤细胞的凋亡细胞死亡。”Anticancer Res.. 23. 3247-3254 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H.Suzuki et al.: "Retrovirus-mediated transduction of TRAIL and chemotherapeutic agents co- operatively induce apoptotic cell death in both sarcoma and myeloma cells."Anticancer Res.. 23. 3247-3254 (2003)
H.Suzuki 等人:“逆转录病毒介导的 TRAIL 转导和化疗药物协同诱导肉瘤和骨髓瘤细胞中的细胞凋亡。”Anticancer Res.. 23. 3247-3254 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
D.Nakayama: "Turnover of acinar and islet cells in the pancreas of monosodium glutamate-treated obese mice."Obes Res.. 11. 87-94 (2003)
D.Nakayama:“谷氨酸钠治疗的肥胖小鼠胰腺中腺泡和胰岛细胞的周转。”Obes Res.. 11. 87-94 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOSHIMOTO Takayuki其他文献
YOSHIMOTO Takayuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOSHIMOTO Takayuki', 18)}}的其他基金
Study on the regulation of immune responses by a novel IL-6/IL-12 family cytokine
新型IL-6/IL-12家族细胞因子调节免疫反应的研究
- 批准号:
24370058 - 财政年份:2012
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Immune regulation by the IL-6/IL-12 family cytokines
IL-6/IL-12 家族细胞因子的免疫调节
- 批准号:
20370049 - 财政年份:2008
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Construction of the Remote Education Network for Exchange of Musical Culture
音乐文化交流远程教育网络建设
- 批准号:
12680259 - 财政年份:2000
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on the role of IL-12 in protective immunity against infection
IL-12在感染保护性免疫中的作用研究
- 批准号:
09044265 - 财政年份:1997
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for international Scientific Research
相似海外基金
The role of sphingosine kinase 2 in mitochondrial dysfunction and NAFLD
鞘氨醇激酶 2 在线粒体功能障碍和 NAFLD 中的作用
- 批准号:
10607244 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Sphingosine kinase 2 in sexual dimorphism of hepatocellular carcinoma
鞘氨醇激酶2在肝细胞癌性别二态性中的作用
- 批准号:
10521724 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Nuclear sphingosine kinase 2 in Huntington disease
亨廷顿病中的核鞘氨醇激酶 2
- 批准号:
10634629 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Nuclear sphingosine kinase 2 in Huntington disease
亨廷顿病中的核鞘氨醇激酶 2
- 批准号:
10414986 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Nuclear sphingosine kinase 2 in Huntington disease
亨廷顿病中的核鞘氨醇激酶 2
- 批准号:
10256616 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
The role of Sphingosine Kinase 2 in alcoholic liver disease
鞘氨醇激酶 2 在酒精性肝病中的作用
- 批准号:
9763388 - 财政年份:2017
- 资助金额:
$ 2.24万 - 项目类别:
The role of Sphingosine Kinase 2 in alcoholic liver disease
鞘氨醇激酶 2 在酒精性肝病中的作用
- 批准号:
9467984 - 财政年份:2017
- 资助金额:
$ 2.24万 - 项目类别:
Targeting sphingosine kinase 2 for the treatment of multiple myeloma
靶向鞘氨醇激酶 2 治疗多发性骨髓瘤
- 批准号:
9527057 - 财政年份:2015
- 资助金额:
$ 2.24万 - 项目类别:
Mechanisms of regulation and biological roles of sphingosine kinase 2
鞘氨醇激酶2的调控机制和生物学作用
- 批准号:
nhmrc : 626936 - 财政年份:2010
- 资助金额:
$ 2.24万 - 项目类别:
NHMRC Project Grants